Dr. James E. Beitzel, MD

Dr. Beitzel practices at Parkview Whitley Hospital in Columbia City, Indiana, part of Parkview Health System.

Dr. Beitzel's NPI, 1912901851, was assigned on June 9, 2005. Dr. Beitzel graduated from Temple University School of Medicine in 1984. Dr. Beitzel holds Indiana license 01061931A.

Dr. Beitzel's primary practice is Parkview Whitley Hospital, at 1260 E Sr 205, Columbia City, IN 46725 in Whitley County. The practice phone is (260) 248-9301.

Dr. Beitzel's primary practice is Parkview Whitley Hospital in Columbia City, Indiana, part of Parkview Health System. Dr. Beitzel is also affiliated with Parkview Regional Medical Center. The medical group on file is Parkview Physicians Group. Dmand AI also links Dr. Beitzel to 3 more hospitals, 3 home health agencies, 1 group practice or clinic and 1 hospice, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Beitzel practices, 10 sites in all. Vendor and product names are available with a free account.

Family medicine is Dr. Beitzel's primary specialty in the NPI Registry, under taxonomy code 207Q00000X. Dmand AI has Dr. Beitzel's licenses on file in 2 states: Indiana and Pennsylvania.

CMS data shows 782 Medicare services from Dr. Beitzel across 9 procedure codes in 2024, for 331 Medicare patients. Medicare paid $45,223 for them. Every service was in an office.

CMS counts 331 Medicare patients who saw Dr. Beitzel in 2024. The largest group is 65 to 74, with 138 patients. 70% of them have high blood pressure, and 68% have high cholesterol. 17% are also on Medicaid. Their average risk score is 1.02, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Beitzel's median patient age at 71, with 51% women.

In 2024, Dr. Beitzel wrote 21,869 Medicare Part D claims for 1,136 patients. 88% of them were for generic drugs. CMS names the drug for 21,016 of them, across 227 drugs with 11 or more claims each, at $1,376,607 in total drug cost. In 2023, CMS named 21,181 claims across 226 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 84 out of 100 for Dr. Beitzel for performance year 2024, reported as part of a group. Dr. Beitzel accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Beitzel as offering telehealth.

Removal of skin lesions: 1 to 10 procedures (CMS shows small counts as a range)

CMS Open Payments shows 1,442 general payments to Dr. Beitzel from 58 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 99% of the total. Abbvie Inc. paid the most, $2,261.

Dr. Beitzel graduated from Temple University School of Medicine in 1984.